Does ENZALUTAMIDE Cause Hospitalisation? 365 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 365 reports of Hospitalisation have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.7% of all adverse event reports for ENZALUTAMIDE.
365
Reports of Hospitalisation with ENZALUTAMIDE
0.7%
of all ENZALUTAMIDE reports
74
Deaths
364
Hospitalizations
How Dangerous Is Hospitalisation From ENZALUTAMIDE?
Of the 365 reports, 74 (20.3%) resulted in death, 364 (99.7%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 365 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which ENZALUTAMIDE Alternatives Have Lower Hospitalisation Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE